SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Themis Medicare - Quaterly Results

20 May 2025 Evaluate
Net sales declined -26.70%  to  Rs. 717.02 million from Rs. 978.18 millions.The Net Loss for the quarter ended March 2025 is Rs. -77.44 millions as compared to Net Profit of Rs. 30.92 millions of corresponding quarter ended March 2024Operating profit Margin for the quarter ended March 2025 slipped to -42.24% as compared to 104.14% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 717.02 978.18 -26.70 4055.12 3817.61 6.22 4055.12 3817.61 6.22
Other Income 15.52 11.00 41.09 46.70 47.56 -1.81 46.70 47.56 -1.81
PBIDT -42.24 104.14 -140.56 537.32 562.89 -4.54 537.32 562.89 -4.54
Interest 24.50 21.61 13.37 100.39 93.76 7.07 100.39 93.76 7.07
PBDT -66.74 82.53 -180.87 436.93 469.13 -6.86 436.93 469.13 -6.86
Depreciation 25.32 30.55 -17.12 99.29 122.46 -18.92 99.29 122.46 -18.92
PBT -92.06 51.98 -277.11 337.64 346.67 -2.60 337.64 346.67 -2.60
TAX -14.62 21.06 -169.42 98.42 99.20 -0.79 98.42 99.20 -0.79
Deferred Tax 10.38 3.36 208.93 15.42 7.00 120.29 15.42 7.00 120.29
PAT -77.44 30.92 -350.45 239.22 247.47 -3.33 239.22 247.47 -3.33
Equity 92.04 92.04 0.00 92.04 92.04 0.00 92.04 92.04 0.00
PBIDTM(%) -5.89 10.65 -155.33 13.25 14.74 -10.13 13.25 14.74 -10.13

Themis Medicare Share Price

90.25 4.97 (5.83%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×